Fair Value Measurements - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	May 03, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Payments related to the settlement of the contingent consideration liability, Financing activities	$ 78	$ 2,568
Payments related to the settlement of the contingent consideration liability, Operating activities	27	26
Impairment of equity method investment	0	0
Impairment of intangible assets	0	0
Interest income	7,276	131
Investments in privately held companies	19,400	19,100
Long-term notes receivable, net	8,500		$ 3,200
Long-term notes receivable issued	6,200
Allowance for expected credit losses	1,388	$ 290	568		$ 281
Solo Pace
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term notes receivable issued	$ 1,500
Fluidx
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Ownership percentage	19.90%
Long-term notes receivable issued	$ 3,000
Bluegrass Vascular Technologies, Inc
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Ownership percentage				19.50%
Equity method investment				$ 245
Selio
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Long-term notes receivable issued	1,700
Allowance for expected credit losses	1,400		600
Other long-term obligations
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability, noncurrent	2,800		3,000
Accrued expenses
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration liability, current	$ 400		$ 400